Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231).
D000818:Animals; D002271:Carbutamide / Q000494:pharmacology; D003864:Depression, Chemical; D003981:Diazoxide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006539:Heptoses / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000494:pharmacology
D006539:Heptoses; D007004:Hypoglycemic Agents; D007328:Insulin; D014044:Tolbutamide; D002271:Carbutamide; D005947:Glucose; D003981:Diazoxide; D004837:Epinephrine